Stock analysts at StockNews.com assumed coverage on shares of NuVasive (NASDAQ:NUVA – Get Rating) in a report issued on Thursday. The brokerage set a “hold” rating on the medical device company’s stock. NUVA has been the subject of several other reports. Barclays boosted their target price on shares of NuVasive from $53.00 to $56.00 in […]